Skip to main content
SpringerLink
Log in

Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Cancer patients have often been reported to have impaired immune function, and the effect of treatment modalities, such as surgery, irradiation, and chemotherapy, in depressing patients’ immunity has also been reported. In this investigation, the effect of treatment on the cellular immunity of esophageal cancer patients was evaluated.

Methods: Immunological parameters, such as natural killer (NK) activity and lymphocyte subsets in peripheral blood, were measured in 32 esophageal cancer patients on 5 occasions (on the day of admission, 2 days before surgery, and 1 week, 1 month, and 2 months after surgery).

Results: NK activity was greatly impaired shortly after the operation, and the percentages of lymphocytes as a whole, and CD8+, CD16+, and CD57+ lymphocytes were significantly decreased, on the other hand, a postoperative increase in the CD4+/CD8+ ratio was observed. No significant depression of immune function by postoperative irradiation was observed.

Conclusions: The results of this study suggest that cellular immunity, especially cytotoxicity, shortly after esophagectomy may be greatly impaired by the surgical stress of esophagectomy and an added effect of chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Collard JM, Otte JB, Reynaert MS, et al. Extensive lymph node clearance for cancer of the esophagus or cardia: merits and limits in reference to 5-year absolute survival.Hepatogastroenterology 1995;42:619–27.

    PubMed  CAS  Google Scholar 

  2. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.N Engl J Med 1998;339:1979–84.

    Article  PubMed  CAS  Google Scholar 

  3. Japanese Society for Diseases of Esophagus. Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Kanehara, Tokyo 1992.

  4. Haffejee AA, Angorn IB. Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma.Ann Surg 1879;189:475–9.

    Google Scholar 

  5. Lozac’h P, Corbeau P, Zabbe C, Charles JF, Youinou P. Peripheral blood and tumor-infiltrating mononuclear cell analysis in esophagus and head and neck cancer.Med Oncol Tumor Pharmachother 1987;4:7–10.

    CAS  Google Scholar 

  6. Tsutsui S, Sonoda K, Sumiyoshi K, et al. Prognostic significance of immunological parameters in patients with esophageal cancer.Hepatogastroenterol 1996;43:501–9.

    CAS  Google Scholar 

  7. Herberman RB, Ortaldo JR. Natural killer cells: their role in defense against disease.Science 1981;214:24–30.

    Article  PubMed  CAS  Google Scholar 

  8. Minato N, Bloom BR, Jones C, Holland J, Reid LM. Mechanism of rejection of virus persistently infected tumor cells by athymic mice.J Exp Med 1979;149:1117–33.

    Article  PubMed  CAS  Google Scholar 

  9. Riddle PR, Berenbaum MC. Post-operative depression of the lymphocyte response to phytohaemagglutinin.Lancet 1967;1:746–8.

    Article  PubMed  CAS  Google Scholar 

  10. Park SK, Brody JI, Wallace HA, Blakemore WS. Immunosuppressive effect of surgery.Lancet 1971;1:53–5.

    Article  PubMed  CAS  Google Scholar 

  11. Miller GC, Pritchard DJ, Ritts RE, Ivins JC, Pierre RV. Effect of surgery on quantity of lymphocyte subpopulations.J Surg Res 1976;21:155–8.

    Article  PubMed  CAS  Google Scholar 

  12. Hansbrough JF, Bender EM, Zapata-Sirvent R, Anderson J. Altered helper and suppressor lymphocyte populations in surgical patients.Am J Surg 1984;148:303–7.

    Article  PubMed  CAS  Google Scholar 

  13. Yoshihara H, Tanaka N, Orita K. Suppression of natural killer cell activity by surgical stress in cancer patients and underlying mechanisms.Acta Med Okayama 1986;40:113–9.

    PubMed  CAS  Google Scholar 

  14. Roth JA, Golub SH, Grimm EA, Eiber FR, Morton DL. Effect of operation on immune response in cancer patients. Sequential evaluation of in vitro lymphocyte function.Surgery 1976;79:46–51.

    PubMed  CAS  Google Scholar 

  15. Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma.J Surg Oncol 1992;49:176–81.

    Article  PubMed  CAS  Google Scholar 

  16. Gupta S, Good RA. Subpopulations of human T-lymphocytes: II. Effect of thymopoietin, corticosteroids and irradiation.Cell Immunol 1977;34:10–18.

    Article  PubMed  CAS  Google Scholar 

  17. Petrini B, Wasserman J, Biberfeld J, Baral E, Blomgren H. The effect of in vitro irradation on PHA-mediated cytotoxicity and lymphocytes with receptors for the Fc part of Ig.J Clin Lab Immunol 1979;2:333–6.

    PubMed  CAS  Google Scholar 

  18. Schulof RS, Chorba TL, Cleary PA, Palaszynski SR, Alabaster O, Goldsteim AL. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.Cancer 1985;55:974–83.

    Article  PubMed  CAS  Google Scholar 

  19. Mandeville R, Sidrac-Ghali S, Ajdukovic I, Vidal D, Ayoub J. Early inhibition of natural and interferon-activated killers in endometrial cancer patients treated with local radiotherapy.Cancer Detect Prevent 1987;10:129–39.

    PubMed  CAS  Google Scholar 

  20. Lennard TW, Shenton BK, Borzotta A, et al. The influence of surgical operations on components of the human immune system.Br J Surg 1985;72:771–6.

    Article  PubMed  CAS  Google Scholar 

  21. Lundy J, Lovett EJ, Hamilton S, Conran P. Immune impairment and metastatic tumor growth.Cancer 1979;43:945–51.

    Article  PubMed  CAS  Google Scholar 

  22. Talmage JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumor growth and metastasis in beige mice.Nature 1980;284:622–4.

    Article  Google Scholar 

  23. Hanna N, Fidler IJ. Role of natural killer cells in the destruction of circulating tumor emboli.J Natl Cancer Inst 1980;65:801–9.

    PubMed  CAS  Google Scholar 

  24. Wang BS, Heacock EH, Wu AVO, Mannick JA. Generation of suppressor cells in mice after surgical trauma.J Clin Invest 1980;66:200–9.

    Article  PubMed  CAS  Google Scholar 

  25. Meakins JL, Pietsch JB, Christou NV, et al. Predicting surgical infection before the operation.World J Surg 1980;4:439–50.

    Article  PubMed  CAS  Google Scholar 

  26. Advani SH, Kutty PM, Gopal R, et al. Immunity in esophageal carcinoma.J Surg Oncol 1983;24:268–73.

    Article  PubMed  CAS  Google Scholar 

  27. Saito T, Shimoda K, Kinoshita T, et al. Prediction of operative mortality based on host defense sysytems in patients with esophageal cancer.J Surg Oncol 1993;52:1–8.

    Article  PubMed  CAS  Google Scholar 

  28. Christou NV, Meakins JL, Gotto D, MacLean LD. Influence of gastrointestinal bleeding on host defence and susceptibility to infection.Surg Forum 1979;30:46–52.

    PubMed  CAS  Google Scholar 

  29. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery.Br J Surg 1988;75:789–92.

    Article  PubMed  CAS  Google Scholar 

  30. Burrow L, Tartter P. Effect of blood transfusions on clonic malignancy recurrence rate.Lancet 1982;2:662.

    Article  Google Scholar 

  31. Foster RS, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer.Cancer 1985;55:1195–1201.

    Article  PubMed  Google Scholar 

  32. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion.BMJ 1985;290:1037–39.

    Article  PubMed  CAS  Google Scholar 

  33. Parrott NR, Lennard TWJ, Taylor RMR, Proud G, Shenton BK, Johnston IDA. Effect of perioperative blood transfusion on recurrence of colorectal cancer.Br J Surg 1986;73:970–3.

    Article  PubMed  CAS  Google Scholar 

  34. Francis DMA, Judson RT. Blood transfusion and recurrence of cancer of the colon and rectum.Br J Surg 1987;74:26–30.

    Article  PubMed  CAS  Google Scholar 

  35. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer cell activity in recipients of repeated blood transfusions.Blood 1984;64:308–10.

    PubMed  CAS  Google Scholar 

  36. Waymack JP, Gallon L, Barcelli U, Trocki O, Alexander W. Effect of blood transfusion on immune function. III. Alternations in macrophage arachidonic acid metabolism.Arch Surg 1987;122:56–60.

    PubMed  CAS  Google Scholar 

  37. Waymack JP, Rapien J, Garnett D, Tweddell JS, Alexander W. Effect of transfusion on immune function in a traumatized animal model.Arch Surg 1986;121:50–5.

    PubMed  CAS  Google Scholar 

  38. Fernandez LA, MacSween JM, You CK, Gorelick M. Immunologic changes after blood transfusion in patients undergoing vascular surgery.Am J Surg 1992;163:263–9.

    Article  PubMed  CAS  Google Scholar 

  39. Cosimi AB, Brunstetter FH, Kemmerer WT, Miller BN. Cellullar immune competence of breast cancer patients receiving radiotherapy.Arch Surg 1973;107:531–5.

    PubMed  CAS  Google Scholar 

  40. Nordman E, Toivanen A. Effects of irradiation on the immune function in patients with mammary, pulmonary or head and neck carcinoma.Acta Radiol Oncol 1978;17:3–9.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, the University of Tokyo Graduate School of Medicine, Tokyo

    Ken-ichi Mafune MD, PhD

  2. the Department of Surgery, Saitama Cancer Center Hospital, Saitama, Japan

    Yoichi Tanaka MD

Authors
  1. Ken-ichi Mafune MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoichi Tanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken-ichi Mafune MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mafune, Ki., Tanaka, Y. Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. Ann Surg Oncol 7, 609–616 (2000). https://doi.org/10.1007/BF02725341

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02725341

Key Words

Search

Navigation